NanoCBD

N/A

Report date: 2025/01/26 16:17:34
NME

Base Information

Drug NameNanoCBD
Drug Alias NameCBD (Medlab Clinical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedlab Clinical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMedlab Clinical Ltd
Inactive CompaniesN/A
Active IndicationsAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A